vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and TEXAS CAPITAL BANCSHARES INC (TCBI). Click either name above to swap in a different company.
TEXAS CAPITAL BANCSHARES INC is the larger business by last-quarter revenue ($324.0M vs $205.4M, roughly 1.6× COLLEGIUM PHARMACEUTICAL, INC). TEXAS CAPITAL BANCSHARES INC runs the higher net margin — 22.8% vs 8.3%, a 14.5% gap on every dollar of revenue. On growth, TEXAS CAPITAL BANCSHARES INC posted the faster year-over-year revenue change (15.5% vs 12.9%). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 10.2%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Texas Capital Bank is a bank headquartered in Dallas, Texas. The bank has branches located in every major city in Texas. Its parent bank holding company is Texas Capital Bancshares. It also operates an online-only banking division, Bask Bank.
COLL vs TCBI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $324.0M |
| Net Profit | $17.0M | $73.8M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | — |
| Net Margin | 8.3% | 22.8% |
| Revenue YoY | 12.9% | 15.5% |
| Net Profit YoY | 35.3% | 56.8% |
| EPS (diluted) | $0.48 | $1.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $324.0M | ||
| Q4 25 | $205.4M | $327.5M | ||
| Q3 25 | $209.4M | $340.4M | ||
| Q2 25 | $188.0M | $307.5M | ||
| Q1 25 | $177.8M | $280.5M | ||
| Q4 24 | $181.9M | $229.6M | ||
| Q3 24 | $159.3M | $125.3M | ||
| Q2 24 | $145.3M | $267.0M |
| Q1 26 | — | $73.8M | ||
| Q4 25 | $17.0M | $100.7M | ||
| Q3 25 | $31.5M | $105.2M | ||
| Q2 25 | $12.0M | $77.3M | ||
| Q1 25 | $2.4M | $47.0M | ||
| Q4 24 | $12.5M | $71.0M | ||
| Q3 24 | $9.3M | $-61.3M | ||
| Q2 24 | $19.6M | $41.7M |
| Q1 26 | — | — | ||
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — |
| Q1 26 | — | — | ||
| Q4 25 | 29.6% | 40.4% | ||
| Q3 25 | 29.7% | 40.5% | ||
| Q2 25 | 18.7% | 33.2% | ||
| Q1 25 | 12.2% | 21.6% | ||
| Q4 24 | 20.9% | 40.7% | ||
| Q3 24 | 21.9% | -63.8% | ||
| Q2 24 | 32.7% | 21.9% |
| Q1 26 | — | 22.8% | ||
| Q4 25 | 8.3% | 30.7% | ||
| Q3 25 | 15.0% | 30.9% | ||
| Q2 25 | 6.4% | 25.2% | ||
| Q1 25 | 1.4% | 16.8% | ||
| Q4 24 | 6.9% | 30.9% | ||
| Q3 24 | 5.9% | -48.9% | ||
| Q2 24 | 13.5% | 15.6% |
| Q1 26 | — | $1.56 | ||
| Q4 25 | $0.48 | $2.11 | ||
| Q3 25 | $0.84 | $2.18 | ||
| Q2 25 | $0.34 | $1.58 | ||
| Q1 25 | $0.07 | $0.92 | ||
| Q4 24 | $0.36 | $1.43 | ||
| Q3 24 | $0.27 | $-1.41 | ||
| Q2 24 | $0.52 | $0.80 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | — |
| Total DebtLower is stronger | — | $878.3M |
| Stockholders' EquityBook value | $301.7M | $3.6B |
| Total Assets | $1.7B | $33.5B |
| Debt / EquityLower = less leverage | — | 0.24× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $386.7M | — | ||
| Q3 25 | $285.9M | — | ||
| Q2 25 | $222.2M | — | ||
| Q1 25 | $197.8M | — | ||
| Q4 24 | $162.8M | — | ||
| Q3 24 | $120.0M | — | ||
| Q2 24 | $271.6M | — |
| Q1 26 | — | $878.3M | ||
| Q4 25 | — | $620.6M | ||
| Q3 25 | — | $620.4M | ||
| Q2 25 | — | $620.3M | ||
| Q1 25 | — | $660.5M | ||
| Q4 24 | — | $660.3M | ||
| Q3 24 | — | $660.2M | ||
| Q2 24 | — | $660.0M |
| Q1 26 | — | $3.6B | ||
| Q4 25 | $301.7M | $3.6B | ||
| Q3 25 | $274.8M | $3.6B | ||
| Q2 25 | $232.2M | $3.5B | ||
| Q1 25 | $234.4M | $3.4B | ||
| Q4 24 | $228.8M | $3.4B | ||
| Q3 24 | $234.3M | $3.4B | ||
| Q2 24 | $216.6M | $3.2B |
| Q1 26 | — | $33.5B | ||
| Q4 25 | $1.7B | $31.5B | ||
| Q3 25 | $1.6B | $32.5B | ||
| Q2 25 | $1.6B | $31.9B | ||
| Q1 25 | $1.6B | $31.4B | ||
| Q4 24 | $1.7B | $30.7B | ||
| Q3 24 | $1.6B | $31.6B | ||
| Q2 24 | $1.1B | $29.9B |
| Q1 26 | — | 0.24× | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.17× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.19× | ||
| Q4 24 | — | 0.20× | ||
| Q3 24 | — | 0.20× | ||
| Q2 24 | — | 0.21× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | — |
| Free Cash FlowOCF − Capex | $122.4M | — |
| FCF MarginFCF / Revenue | 59.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $123.0M | $360.2M | ||
| Q3 25 | $78.4M | $166.3M | ||
| Q2 25 | $72.4M | $63.0M | ||
| Q1 25 | $55.4M | $368.0K | ||
| Q4 24 | $84.6M | $480.1M | ||
| Q3 24 | $-9.0M | $332.8M | ||
| Q2 24 | $67.4M | $33.3M |
| Q1 26 | — | — | ||
| Q4 25 | $122.4M | $347.6M | ||
| Q3 25 | $78.3M | $161.3M | ||
| Q2 25 | $72.4M | $57.5M | ||
| Q1 25 | $54.6M | $-2.0M | ||
| Q4 24 | $84.1M | $415.2M | ||
| Q3 24 | $-9.2M | $317.6M | ||
| Q2 24 | $67.1M | $11.1M |
| Q1 26 | — | — | ||
| Q4 25 | 59.6% | 106.1% | ||
| Q3 25 | 37.4% | 47.4% | ||
| Q2 25 | 38.5% | 18.7% | ||
| Q1 25 | 30.7% | -0.7% | ||
| Q4 24 | 46.2% | 180.9% | ||
| Q3 24 | -5.8% | 253.4% | ||
| Q2 24 | 46.2% | 4.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 3.8% | ||
| Q3 25 | 0.1% | 1.5% | ||
| Q2 25 | 0.0% | 1.8% | ||
| Q1 25 | 0.4% | 0.9% | ||
| Q4 24 | 0.3% | 28.2% | ||
| Q3 24 | 0.2% | 12.1% | ||
| Q2 24 | 0.2% | 8.3% |
| Q1 26 | — | — | ||
| Q4 25 | 7.25× | 3.58× | ||
| Q3 25 | 2.49× | 1.58× | ||
| Q2 25 | 6.05× | 0.81× | ||
| Q1 25 | 22.92× | 0.01× | ||
| Q4 24 | 6.75× | 6.76× | ||
| Q3 24 | -0.96× | — | ||
| Q2 24 | 3.44× | 0.80× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
